Clinical trialNCT06786429Not, yet, recruitingPhase 4Interventional

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

SponsorEunice DubeEnrollment2,140Cancer LiverCancer of CervixDepression, AnxietyHepatitis BHuman Papilloma VirusMental Health Issue

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Aim: The main goal of this quantitative epidemiological observational study is to determine the prevalence of Human Papilloma Virus (HPV) infection and Hepatitis B (Hep B) immunity amongst women of childbearing age. attending clinics at Mtshabezi Mission and Matobo clinic respectively, and assessing behavioral risk factors of high school students at these catchment areas that can put them at risk for developing cancer of the cervix and liver. Question: Can screening for cancer, vaccination against Hep B and HPV, and cognitive behavior intervention help in preventing related cancers amongst these groups of participants?

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Desmond M Kaplan, MD
Principal Investigator
clinicaltrials.gov ↗
Elopy Sibanda, M.D
National University of Science and Technology, Zimbabwe
Study Director
clinicaltrials.gov ↗
Eunice Dube, DSc
Eunice Dube
Principal Investigator
clinicaltrials.gov ↗
Jill Koshiol, Ph. D
National Cancer Institute (NCI)
Principal Investigator
clinicaltrials.gov ↗
Sodumisa Ngwenya, MD
Mtshabezi Mission Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Gardasil 9 vaccineHepatitis B surface antigen vaccine →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jan 2027
Primary completion: 15 Dec 2032
Completion: 15 Dec 2032
Last update posted: 30 Jul 2026
Registered enrollment: 2,140
Registry id: NCT06786429

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.